Keywords: مولتیپل میلوما; Multiple myeloma; Mobilization; Apheresis;
مقالات ISI مولتیپل میلوما (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مولتیپل میلوما; Multiple myeloma; Breast cancer; Diagnosis; Treatment;
Keywords: مولتیپل میلوما; Multiple myeloma; Trabecular bone score; Fractures;
Keywords: مولتیپل میلوما; Sellar; Plasmacytoma; Pituitary; Intracranial; Multiple myeloma;
Keywords: مولتیپل میلوما; Multiple myeloma; Bone infarct; Osteosclerosis;
Keywords: مولتیپل میلوما; CCI; Charlson Comorbidity Index; MM; multiple myeloma; NHIRD; National Health Insurance Research Database; RCI; Registry of Catastrophic Illness; Multiple myeloma; Epidemiology; Bortezomib; Incidence; Prevalence; Mortality; Asia;
Keywords: مولتیپل میلوما; Multiple myeloma; Incidence; Mortality; Survival; Neoplasms; Registries; Switzerland;
Keywords: مولتیپل میلوما; AMPK; AMP-activated protein kinase; ARF6; ADP-ribosylation factor 6; AKT; protein kinase B; BBB; blood brain barrier; bFGF; b-fibroblast growth factors; b-FGFR; b-fibroblast growth factors receptor; ccRCC; clear cell renal cell carcinoma; ECs; endothelial
Keywords: مولتیپل میلوما; Heavy-light chain assay; Multiple myeloma; Biomarker;
Keywords: مولتیپل میلوما; Multiple Myeloma; Oral Manifestations; Mouth; Jaws;
Keywords: مولتیپل میلوما; Central nervous system; Multiple myeloma; Radiotherapy; Chemotherapy; Prognosis;
Keywords: مولتیپل میلوما; glomerulonephritis; lymphoma; multiple myeloma; onconephrology;
Keywords: مولتیپل میلوما; Magnetic resonance imaging; Minimal Residual Disease; Multiple Myeloma; Treatment Monitoring; Prognosis; Response Assessment;
Keywords: مولتیپل میلوما; Dolor; NeuropatÃa periférica; Bortezomib; Mieloma múltiple; Detección precoz; Repercusiones en las Actividades de la vida diaria; Pain; Peripheral neuropathy; Bortezomib; Multiple myeloma; Early detection; Effects on Activities of daily living;
Keywords: مولتیپل میلوما; GEP; gene expression profiling; PFS; progression free survival; DRP; drug response prediction; TT; Total therapy; IMWG; The International Myeloma Work Group; ASCT; autologous stem cell transplantation; MMSET-high; high expression levels of MMSET; MAF-high
Keywords: مولتیپل میلوما; Liver toxicity; Multiple myeloma; Pomalidomide;
Keywords: مولتیپل میلوما; Donor lymphocyte infusion; Allogeneic stem cell transplantation; Multiple myeloma; Graft-versus-host disease; Minimal residual disease;
Keywords: مولتیپل میلوما; Multiple myeloma; Second primary malignancies; Immunomodulatory drugs; Proteasome inhibitors; Plerixafor;
Keywords: مولتیپل میلوما; Multiple myeloma; Osteolytic lesion; MAST4;
Keywords: مولتیپل میلوما; Red blood cell distribution width; Multiple myeloma; Prognosis; Bortezomib;
Keywords: مولتیپل میلوما; Multiple myeloma; Risk factors; Prognosis; Cytokines;
Keywords: مولتیپل میلوما; Pleural effusion; Pleural fluid; Myelomatous pleural effusion; Multiple myeloma; Pleural cytology; Monoclonal peak; Pleural biopsy; Systematic review; Derrame pleural; LÃquido pleural; Derrame pleural mielomatoso; Mieloma múltiple; CitologÃa pleural; P
Keywords: مولتیپل میلوما; Derrame pleural; LÃquido pleural; Derrame pleural mielomatoso; Mieloma múltiple; CitologÃa pleural; Pico monoclonal; Biopsia pleural; Revisión sistemática; Pleural effusion; Pleural fluid; Myelomatous pleural effusion; Multiple myeloma; Pleural cytol
Keywords: مولتیپل میلوما; Adipose tissue; Multiple myeloma; Adipocytes; Adipokine; Myelomagenesis;
Keywords: مولتیپل میلوما; Multiple myeloma; Toxic death; Early mortality; Newly diagnosed; Transplant-Ineligible; New drugs; Bortezomib; Lenalidomide; Thalidomide;
Keywords: مولتیپل میلوما; NK cells; Multiple myeloma; Immunotherapy;
Keywords: مولتیپل میلوما; CTA; Multiple Myeloma; Immunotherapy; MRD; Cyclins; Cascade;
Keywords: مولتیپل میلوما; Antigen excess; Immunofixation; Multiple myeloma; Nephelometry; Serum free light chains (SFLC);
Keywords: مولتیپل میلوما; Multiple myeloma; Bone disease; Receptor activator of nuclear factor-kB ligand (RANKL); Wnt pathway;
Keywords: مولتیپل میلوما; Multiple myeloma; Bortezomib; Carfilzomib; Proteasome inhibitor;
Keywords: مولتیپل میلوما; mass spectrometry; immunoglobulin; multiple myeloma; minimal residual disease;
Keywords: مولتیپل میلوما; Allogeneic stem cell transplantation; Multiple myeloma; Long-term follow-up;
Keywords: مولتیپل میلوما; Allogeneic transplant; Multiple myeloma; New drugs; Long-term follow-up; Chronic graft-versus-host disease;
Keywords: مولتیپل میلوما; Multiple myeloma; European chart review; Practice patterns; Adverse events; Elderly; Real-world practice;
Keywords: مولتیپل میلوما; discrete choice experiment; hematology; Japan; multiple myeloma; oncologists; treatment preferences;
Keywords: مولتیپل میلوما; Multiple myeloma; Relapsed; Refractory; Elderly; Cytogenetics;
Keywords: مولتیپل میلوما; FRAX; Geriatric; MGUS; Multiple myeloma; Osteoporosis;
Keywords: مولتیپل میلوما; Multiple myeloma; Tumor and environment; Osteoblast and osteoclast populations; Ordinary differential equations; Minimax optimization; Sensitivity analysis;
Keywords: مولتیپل میلوما; daratumumab; relapsed or refractory; multiple myeloma; cost-effectiveness;
Keywords: مولتیپل میلوما; Multiple myeloma; Transplant conditioning; Propylene glycol-free and Captisol-enabled melphalan or Evomela;
Keywords: مولتیپل میلوما; FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: مولتیپل میلوما; comorbidities; hematologic malignancies; leukemia; multiple myeloma; non-Hodgkin lymphoma; pemphigus; CI; confidence interval; OR; odds ratio;
Keywords: مولتیپل میلوما; ASCT; Multiple myeloma; Quality of life; Outpatient; Inpatient;
Keywords: مولتیپل میلوما; Hypogammaglobulinemia; Infections; Multiple myeloma; Quality of life; Subcutaneous immunoglobulin;
Keywords: مولتیپل میلوما; Autologous stem cell transplantation; Bortezomib; High-risk; Multiple myeloma; t(4;14);
Keywords: مولتیپل میلوما; Multiple myeloma; Vaccination; Immunization; Lenalidomide; Maintenance; Autologous transplant;
Keywords: مولتیپل میلوما; Monoclonal protein; Biological variation; Reference change value; Multiple myeloma; MGUS;
Keywords: مولتیپل میلوما; Multiple myeloma; Relapse; Autologous hematopoietic cell transplantation;
Keywords: مولتیپل میلوما; Health-related quality of life; Autologous stem cell transplantation; Multiple myeloma;
Keywords: مولتیپل میلوما; MM; Multiple Myeloma; ISS; Internationla Staging System; R-ISS; Revised International Staging System; CTCs; Circulating tumor cells; ctDNA; Circulating tumor DNA;